In silico Design a vaccine Candidate against Corynebacterium diphtheriae.

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 26

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJMCM-9-1_002

تاریخ نمایه سازی: 19 اسفند 1402

Abstract:

This study was undertaken to select and analyze epitopes of Corynebacterium diphtheriae toxin using online and offline computerized analysis methods, after that affinity of MHC epitopes to HLA-DRB۱*۰۱۰۱ was analyzed by Hex-protein protein software. The B cell epitopes were predicted via Immune Epitope Database (IEDB) and MHC class II epitopes were predicted by Vaxign softwarer. A physicochemical analysis of candidate vaccine revealed that the designed vaccine has a molecular weight of ۵۹.۰۶۲ kD. The estimated half-life of candidate vaccine was found to be greater than ۳۰ hours (mammalian reticulocytes, in vitro), greater than ۲۰ hours (yeast, in vivo), and greater than ۱۰ hours (Escherichia coli, in vivo). The instability index (II) is computed to be ۳۱.۳۱ (<۴۰), the aliphatic index was found to be ۶۵.۸۰, and the vaccine was considered stable. The grand average of hydropathicity was -۰.۵۸۰, therefore, the vaccine is a hydrophilic protein and probably it interacts with molecules of water. The result of allertop, toxinpred showed that the vaccine is non-allergenic and non-tixic. According to the obtained data from protparam and pepcalc, our designed vaccine is soluble and no transmembrane helix was projected, hence no expression difficulties are anticipated in the development of the vaccine. The membrane helices value of vaccine was ۳۳.۶۴%. The result of protein protein docking analysis showed that maximum affinity of candidate vaccine to HLA-DRB۱*۰۱۰۱ with the score of -۶۳۶.۸۵. The result of this study showed that the candidate vaccine can be stimulate HLA-DRB۱*۰۱۰۱.

Authors

Mostafa Norizadeh Tazehkand

Faculty of Pharmacy Department of Pharmaceutical Biotechnology Bulent Ecevit University Zonguldak/ Turkey +۹۰۵۳۷۲۸۹۱۰۲۷

Orkideh Hajipour

Department of Biology, Institute of Basic and Applied Sciences, Pamukkale University, Denizli, Turkey